Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-02-03 @ 2:08 AM
Study NCT ID:
NCT00074867
Status:
COMPLETED
Last Update Posted:
2006-11-07
First Post:
2003-12-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer
Sponsor:
Pfizer
Organization: